PROVIDER PROFILE · NPI 1659323194
Mark Krawitz
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
17
Beneficiaries
—
Total drug cost
$193
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Latanoprost17 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Mark Krawitz's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 64 | 113 |
| ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL INC | 27 | 44 |
| Matthew Gewirtz Ophthalmology · Warren, NJ | 23 | 45 |
| AHS HOSPITAL CORP. | 23 | 33 |
| John Lane Ophthalmology · Warren, NJ | 16 | 29 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 14 | 28 |
| Saleem Husain Cardiology · Plainfield, NJ | 13 | 28 |
| WEINBERGER, GEORGE | 13 | 23 |
| Henry Altszuler Cardiology · Metuchen, NJ | 13 | 21 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE